Sumant Ramachandra
Fortuna: 129 400 $ al 31/07/2026
Fortuna: 129 400 $ al 31/07/2026
En la actualidad, Sumant Ramachandra es vicepresidente senior y director de ciencia y tecnología de Baxter International, Inc. El Dr. Ramachandra también forma parte del consejo de administración de Arog Pharmaceuticals, Inc. Anteriormente, el Dr. Ramachandra ocupó los cargos de Director Científico y Vicepresidente Senior de Asuntos Reglamentarios en Hospira, Inc., Presidente de Investigación y Desarrollo en Synta Pharmaceuticals Corp., Vicepresidente Senior, Jefe de Investigación y Desarrollo en Pfizer Essential Health y Vicepresidente en Schering-Plough Corp. Se licenció en la Universidad Estatal Rutgers de Nueva Jersey, se doctoró en la Universidad de Medicina y Odontología de Nueva Jersey y obtuvo un MBA en la Wharton School de la Universidad de Pensilvania.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
LYELL IMMUNOPHARMA, INC. 0,04 % | 10/06/2026 | 10.000 ( 0,04 % ) | 129 400 $ | 31/07/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| LYELL IMMUNOPHARMA, INC. | Director/Miembro de la Junta | 01/11/2024 |
Arog Pharmaceuticals, Inc.
Arog Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops cancer treatments | Director/Miembro de la Junta | - |
Lutris Pharma Ltd.
Lutris Pharma Ltd. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company that improves anti cancer therapy effectiveness | Director Ejecutivo | 20/04/2025 |
| Empresas | Cargo | Fin |
|---|---|---|
Immpact Bio USA, Inc.
Immpact Bio USA, Inc. BiotechnologyHealth Technology Develops cell therapy for treating cancer | Director Ejecutivo | 31/10/2024 |
| BAXTER INTERNATIONAL INC. | Director Técnico/Científico/I+D | 01/12/2021 |
| HOSPIRA, INC. | Director Técnico/Científico/I+D | 01/01/2015 |
Synta Pharmaceuticals Corp.
Synta Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes novel pharmaceutical products | Director Técnico/Científico/I+D | 05/05/2013 |
Schering-Plough Corp.
Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Manufactures and sells pharmaceutical & health care products | Corporate Officer/Principal | 01/01/2008 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 12 |
|---|---|
Baxter International, Inc.
Baxter International, Inc. Medical SpecialtiesHealth Technology Produces and supplies medical products, healthcare systems, therapies and pharmaceuticals & provide kidney care services | Health Technology |
Schering-Plough Corp.
Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Manufactures and sells pharmaceutical & health care products | Health Technology |
Hospira, Inc.
Hospira, Inc. Pharmaceuticals: MajorHealth Technology Provides drugs, IV sets and clinical integration & software, infusion pumps and implementation services | Health Technology |
Synta Pharmaceuticals Corp.
Synta Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes novel pharmaceutical products | Health Technology |
University of Medicine & Dentistry of New Jersey
University of Medicine & Dentistry of New Jersey Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Rutgers State University of New Jersey
Rutgers State University of New Jersey Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Arog Pharmaceuticals, Inc.
Arog Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops cancer treatments | Health Technology |
The Wharton School of the University of Pennsylvania
The Wharton School of the University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pfizer Essential Health
Pfizer Essential Health Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Lutris Pharma Ltd.
Lutris Pharma Ltd. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company that improves anti cancer therapy effectiveness | Health Technology |
Lyell Immunopharma, Inc.
Lyell Immunopharma, Inc. BiotechnologyHealth Technology Develops cell-based immunotherapies for human diseases | Health Technology |
Immpact Bio USA, Inc.
Immpact Bio USA, Inc. BiotechnologyHealth Technology Develops cell therapy for treating cancer | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.